Genflow Biosciences (LSE:GENF) EBITDA Margin % : 0.00% (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Genflow Biosciences EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Genflow Biosciences's EBITDA for the six months ended in Jun. 2024 was £-0.52 Mil. Genflow Biosciences's Revenue for the six months ended in Jun. 2024 was £0.00 Mil. Therefore, Genflow Biosciences's EBITDA margin for the quarter that ended in Jun. 2024 was 0.00%.

Genflow Biosciences EBITDA Margin % Historical Data

The historical data trend for Genflow Biosciences's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genflow Biosciences EBITDA Margin % Chart

Genflow Biosciences Annual Data

Trend

Dec21

Dec22

Dec23

EBITDA Margin %

Genflow Biosciences Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EBITDA Margin %	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Genflow Biosciences's EBITDA Margin %

For the Biotechnology subindustry, Genflow Biosciences's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genflow Biosciences's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genflow Biosciences's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Genflow Biosciences's EBITDA Margin % falls into.

Save Embed

;

Save Embed

;

Genflow Biosciences EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Genflow Biosciences's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-1.628	/	0
	=	%

Genflow Biosciences's EBITDA Margin % for the quarter that ended in Jun. 2024 is calculated as

EBITDA Margin %	=	EBITDA (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	-0.524	/	0
	=	%

Genflow Biosciences (LSE:GENF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Genflow Biosciences EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Genflow Biosciences's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Genflow Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genflow Biosciences PLC (LSE:GENF) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

GENFF:USA

Address

6 Heddon Street, London, GBR, W1B 4BT

Website

https://www.genflowbio.com

Genflow Biosciences PLC is a preclinical biotechnology company focused on developing innovative biological interventions aimed at tackling the effects of aging, potentially slowing or halting the aging process and reducing the incidence of age-related diseases and thereby increasing life span. The company is also focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with age.

Genflow Biosciences Headlines

No Headlines